These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2248359)

  • 1. In bed together at the market: psychiatry and the pharmaceutical industry.
    Dumont MP
    Am J Orthopsychiatry; 1990 Oct; 60(4):484-5. PubMed ID: 2248359
    [No Abstract]   [Full Text] [Related]  

  • 2. The long arm of financial conflicts of interest: extensions into lined pockets, research and review, and the United States Senate.
    Rivkees SA
    J Pediatr Endocrinol Metab; 2008 Jul; 21(7):607-9. PubMed ID: 18780592
    [No Abstract]   [Full Text] [Related]  

  • 3. Revelations on the state of psychiatry today.
    Flaskerud J
    Issues Ment Health Nurs; 2011; 32(4):266-8. PubMed ID: 21355762
    [No Abstract]   [Full Text] [Related]  

  • 4. Not in our methods, but in our ignorance.
    Leber P
    Arch Gen Psychiatry; 2002 Mar; 59(3):279-80. PubMed ID: 11879166
    [No Abstract]   [Full Text] [Related]  

  • 5. Out of the box.
    Gelenberg AJ
    Arch Gen Psychiatry; 2002 Mar; 59(3):281. PubMed ID: 11879167
    [No Abstract]   [Full Text] [Related]  

  • 6. Critical thinking about adverse drug effects: lessons from the psychology of risk and medical decision-making for clinical psychopharmacology.
    Nierenberg AA; Smoller JW; Eidelman P; Wu YP; Tilley CA
    Psychother Psychosom; 2008; 77(4):201-8. PubMed ID: 18418026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Code of conduct for psychiatrist - established on behalf of the Austrian Society for Psychiatry and Psychotherapy].
    Hinterhuber vH; Lehofer M; Ofner H; Stuppäck C;
    Neuropsychiatr; 2009; 23(4):263-6. PubMed ID: 19909698
    [No Abstract]   [Full Text] [Related]  

  • 8. Pediatric psychopharmacological research in the post EU regulation 1901/2006 era.
    Schmäl C; Becker K; Berg R; Brünger M; Lehmkuhl G; Oehler KU; Ruppert T; Staudter C; Trott GE; Dittmann RW
    Z Kinder Jugendpsychiatr Psychother; 2014 Nov; 42(6):441-9. PubMed ID: 25335522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some ethical problems in psychiatry.
    Blomquist CD
    Ethics Sci Med; 1979; 6(2):105-14. PubMed ID: 477653
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug therapy in child and adolescent psychiatry in Germany between ethical as well as social and legal conflicts].
    Gerlach M; Warnke A
    Z Kinder Jugendpsychiatr Psychother; 2016; 44(4):249-55. PubMed ID: 27434686
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bitter and gilded pills: psychiatry in the light (or shadow) of the pharmaceutical industry].
    Vandereycken W
    Tijdschr Psychiatr; 2006; 48(2):119-29. PubMed ID: 16958195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of pharmaceutical companies in research and development--plaudits and cautions.
    Rae-Grant Q
    Can J Psychiatry; 2002 Aug; 47(6):513. PubMed ID: 12211877
    [No Abstract]   [Full Text] [Related]  

  • 13. [Family practice and psychiatry: 2 different areas, a large interface].
    Hoff P
    Praxis (Bern 1994); 2014 Jun; 103(13):735. PubMed ID: 24938153
    [No Abstract]   [Full Text] [Related]  

  • 14. [A storm is brewing around the DSM V (the new anti-psychiatry)].
    Bourgeois ML
    Encephale; 2014 Feb; 40(1):1-2. PubMed ID: 24439789
    [No Abstract]   [Full Text] [Related]  

  • 15. [Consultation-liaison psychiatry].
    Horikawa N
    Seishin Shinkeigaku Zasshi; 2007; 109(7):709-11. PubMed ID: 17969961
    [No Abstract]   [Full Text] [Related]  

  • 16. This prescription may be hazardous to your health: who is accountable to the patient?
    Walsh CB
    J Clin Psychopharmacol; 1993 Feb; 13(1):68-70. PubMed ID: 8486819
    [No Abstract]   [Full Text] [Related]  

  • 17. [Editorial: Hebebrand, J., Blanz, B., Herpertz-Dahlmann, B. & Lehmkuhl, G. 2012. Increase in the abundance of medical treatments, ethical principles and conflicts of interest in cooperation with the pharmaceutical industry].
    Frank R
    Z Kinder Jugendpsychiatr Psychother; 2013 Mar; 41(2):145-9. PubMed ID: 23425616
    [No Abstract]   [Full Text] [Related]  

  • 18. [The new German drug market law AMNOG from a child and adolescent psychiatry perspective].
    Dittmann RW
    Nervenarzt; 2016 Apr; 87(4):367-75. PubMed ID: 26992908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reaction to 'Bitter and gilded pills: psychiatry in the light (or shadow) of the pharmaceutical industry' and to 'The importance of public-private cooperation. Comment on Vandereycken'].
    Buis WM
    Tijdschr Psychiatr; 2006; 48(6):500-1; author reply 501-3. PubMed ID: 16956013
    [No Abstract]   [Full Text] [Related]  

  • 20. 'Big pharma' and psychiatry: 'the devil is in the dyad'.
    Anand S
    Aust N Z J Psychiatry; 2012 Dec; 46(12):1118-9. PubMed ID: 23212138
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.